259 related articles for article (PubMed ID: 17934261)
1. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
Walsh F; Bracher S; Turner P; Amyes S
Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase.
Ho SE; Subramaniam G; Palasubramaniam S; Navaratnam P
Antimicrob Agents Chemother; 2002 Oct; 46(10):3286-7. PubMed ID: 12234862
[TBL] [Abstract][Full Text] [Related]
3. IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
Sader HS; Reis AO; Silbert S; Gales AC
Clin Microbiol Infect; 2005 Jan; 11(1):73-6. PubMed ID: 15649310
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.
Meletis G; Vavatsi N; Exindari M; Protonotariou E; Sianou E; Haitoglou C; Sofianou D; Pournaras S; Diza E
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):253-8. PubMed ID: 24062236
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of metallo-beta-lactamase in carbapenem resistant Pseudomonas aeruginosa at a university hospital of Buenos Aires City].
Pagniez G; Radice M; Cuirolo A; Rodríguez O; Rodríguez H; Vay C; Famiglietti A; Gutkind G
Rev Argent Microbiol; 2006; 38(1):33-7. PubMed ID: 16784133
[TBL] [Abstract][Full Text] [Related]
6. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
7. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
Karampatakis T; Antachopoulos C; Tsakris A; Roilides E
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1211-1220. PubMed ID: 29644540
[TBL] [Abstract][Full Text] [Related]
9. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
[TBL] [Abstract][Full Text] [Related]
10. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
van der Bij AK; Mol M; van Westreenen M; Goessens WH; Pitout JD
Scand J Infect Dis; 2011 Aug; 43(8):596-602. PubMed ID: 21506891
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
12. IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa.
Tada T; Miyoshi-Akiyama T; Shimada K; Shimojima M; Kirikae T
Antimicrob Agents Chemother; 2013 Sep; 57(9):4427-32. PubMed ID: 23836174
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of Imipenem-Resistant, Meropenem-Susceptible Pseudomonas aeruginosa with blaVIM₋₂ Phenotype: Potential for Dissemination.
Pragasam AK; Raghanivedha M; Anandan S; Veeraraghavan B
Jpn J Infect Dis; 2016; 69(2):159-60. PubMed ID: 26567829
[No Abstract] [Full Text] [Related]
15. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
16. VIM-2 beta-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia.
Bosnjak Z; Bedenić B; Mazzariol A; Jarza-Davila N; Suto S; Kalenić S
Scand J Infect Dis; 2010 Mar; 42(3):193-7. PubMed ID: 20001226
[TBL] [Abstract][Full Text] [Related]
17. Comparison of imipenem and meropenem antibiotics for the MALDI-TOF MS detection of carbapenemase activity.
Rotova V; Papagiannitsis CC; Skalova A; Chudejova K; Hrabak J
J Microbiol Methods; 2017 Jun; 137():30-33. PubMed ID: 28390706
[TBL] [Abstract][Full Text] [Related]
18. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
[TBL] [Abstract][Full Text] [Related]
19. [Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp].
Sacha P; Wieczorek P; Jakoniuk P; Zórawski M
Wiad Lek; 2008; 61(1-3):30-6. PubMed ID: 18717040
[TBL] [Abstract][Full Text] [Related]
20. Variability of the bla(IMP-15)-containing integrons, highly related to In95, on an endemic clone of Pseudomonas aeruginosa in Mexico.
Garza-Ramos JU; Sanchez-Martinez G; Barajas JM; Suarez S; Sanchez-Perez A; Rojas-Moreno T; Carrillo-Quiroz B; Silva-Sanchez J
Microb Drug Resist; 2010 Sep; 16(3):191-5. PubMed ID: 20617927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
